You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
The company reported its first profitable quarter.
In this video, I will be talking about Hims & Hers' (HIMS -6.77%) recent earnings report and why the stock might still be a buy right now despite being up 25% this year already.
*Stock prices used were from the trading day of Feb. 26, 2024. The video was published on Feb. 26, 2024.
Neil Rozenbaum has positions in Hims & Hers Health. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Neil is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
